Objectives: There is growing recognition that a comprehensive economic assessment of a
new health‐care intervention at the time of launch requires both a cost‐effectiveness …

Abstract Background Budget impact analyses (BIAs) are an essential part of a
comprehensive economic assessment of a health care intervention and are increasingly …

Budget impact analysis (BIA) is a relatively recent method for economic evaluation (EE) in
the field of health care. It assesses the financial consequences of the introduction of a new …

A budget impact analysis for a new pharmaceutical product provides estimates of the likely
impact of the new drug on a healthcare decision maker's short-and longer-term annual …

BACKGROUND: Financial analysis (budget impact analysis, BIA) is increasingly required by
decision-makers to ascertain the macroeconomic consequences of new product …

Health economic evaluations are comparative analyses of alternative courses of action in
terms of their costs and consequences. The Consolidated Health Economic Evaluation …

This article reports the recommendations of the Panel on Cost Effectiveness in Health and
Medicine, sponsored by the US Public Health Service, on standardised methods for …

The role of economic evaluation in the efficient allocation of healthcare resources has been
widely debated. Whilst economic evidence is undoubtedly useful to purchasers, it does not …

As health costs in the US soar past $1.5 trillion, much evidence indicates that the nation
does not get good value for its money. It is widely agreed that we could do better by using …

The term cost-effectiveness has become synonymous with health economic evaluation and
has been used (and misused) to depict the extent to which interventions measure up to what …